ResearcherUniversity Hospital BonnNo recent work listed

Maria F. Setiawan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0256-0530; OpenAlex author ID A5034159200. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.13730 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ingo G.H. Schmidt‐Wolf · 1 shared paper, 2019 · strength 0.08
- Paper FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Ce… DOI 10.21873/anticanres.13730 ↗
Maria Angeles Gonzalez-Carmona · 1 shared paper, 2019 · strength 0.08
- Paper FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Ce… DOI 10.21873/anticanres.13730 ↗
Francesca Garofano · 1 shared paper, 2019 · strength 0.08
- Paper FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Ce… DOI 10.21873/anticanres.13730 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.